Sign In  |  Register  |  About Corte Madera  |  Contact Us

Corte Madera, CA
September 01, 2020 10:27am
7-Day Forecast | Traffic

  • Search Hotels in Corte Madera

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Clover Health Investments Corp (NQ: CLOV )

3.360 +0.010 (+0.30%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Clover Health Investments Corp

< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
We Asked, You Answered: What Stock Would You Never Buy Again?
Almost all traders have had that moment: A confident stock pick or strategy that backfires and leaves the investor with less money than they had before and vowing never to trade that stock again. 
Via Benzinga
All Bets Are Off Whether Clover Health Stock Surges or Sinks From Here
It's not for certain CLOV stock spikes after its upcoming earnings report, and a lot needs to happen for it to make a true price recovery. 
Via InvestorPlace
Has Clover Health Finally Bottomed Out?
Clover is delivering improved operational results. Management's better than expected guidance lends positive outlook to CLOV stock. 
Via InvestorPlace
Clover Health’s Technology Is Great But With Dead Money
CLOV Stock has great technology but may lack the financial strength to make it in the Medicare Advantage arena. 
Via InvestorPlace
Clover Health Investments, Corp. (NASDAQ:CLOV) Investor Alert: Update in Lawsuit
San Diego, CA -- (SBWIRE) -- 04/22/2022 -- The Shareholders Foundation announced an update in the lawsuit that is pending for certain investors in shares of Clover Health Investments, Corp.... 
Via SBWire
It’s Time for Clover Health to Think Outside the Box
A possible revenue stream for Clover Health is their policyholder’s health data. Could that be a way to get CLOV stock out of its funk? 
Via InvestorPlace
Don’t Buy CLOV Stock Ahead of Earnings Report
CLOV stock doesn't look good because revenue increases don't trump its greater issues. Don't get in ahead of Q1 earnings. 
Via InvestorPlace
Do Not Think of Clover Stock as a Bargain Yet
Clover Health certainly has the potential, but it carries more risks. Avoid CLOV stock at the current level. 
Via InvestorPlace
The Clover Health Debate Will Likely Settle With a Bullish Victory
The Clover Health debate is a fiery one and it won't settle except in hindsight. Meanwhile, the better opportunity in CLOV stock is upside. 
Via InvestorPlace
Clover Health Stock Is No Longer a Meme Stock
A lack of battleground interest and and Clover Health's improving business bode well for long-term CLOV stock investors. 
Via InvestorPlace
Clover Health Stock May Rise As Millions Could Lose Health Coverage
CLOV stock has been under heavy selling pressure, but brighter days should lie ahead as Clover Health offers insure-tech solutions. 
Via InvestorPlace
Clover Stock’s Recovery Could Reverse in the Short-Term
The rebound in growth stocks, not its fundamentals, has been what is fueling the steady rebound in the price of CLOV stock since March. 
Via InvestorPlace
Clover Health Is Risky But Offers a Healthy Upside Ahead
Clover Health's robust fourth quarter and upbeat guidance has improved the risk/reward opportunity of CLOV stock. 
Via InvestorPlace
Clover Health Stock’s Outlook Has Improved, but It’s Still a Sell
Clover's profitability is improving but remains dismal, while it seems to lack competitive advantages. As a result, CLOV stock is a sell. 
Via InvestorPlace
What’s So Special About Clover Health?
As many underserved U.S. seniors seek affordable healthcare, CLOV stock is transforming an entire industry through data and technology. 
Via InvestorPlace
Clover Health Is in Need of a Break After Massive Upsurge This Past Month
CLOV stock has seen positive momentum since its earnings release. Due to this, it may become a speculative investment again in the short run. 
Via InvestorPlace
Clover Health Is in Dire Straits as Medical Costs Remain High
Clover Health’s medical loss ratio is high. The company is losing money per $1 of revenue it makes. CLOV stock upside could be limited. 
Via InvestorPlace
Clover Health Stock Will Be Your Lucky Four-Leaf Clover in 2022
CLOV stock is high-risk, but potentially also high-reward, as Clover Health rakes in the revenue and helps at-risk patients get healthcare. 
Via InvestorPlace
Executives Buy Around $2M Of 5 Penny Stocks
Crude oil futures traded higher by around 2% on Wednesday. Investors, meanwhile, focused on some notable insider trades When insiders purchase or sell shares, it indicates their confidence or concern... 
Via Benzinga
7 Meme Stocks Still Making a Lot of Noise
You may think the meme stocks trend is over, but these seven Reddit favorites are still receiving a lot of chatter online. 
Via InvestorPlace
Sell Clover Health Stock in the Wake of Its Rally
CLOV stock recently enjoyed a considerable relief rally. However, its fundamentals remain as poor as ever and its gains will be fleeting. 
Via InvestorPlace
Benzinga's Daily Brief On Trending Tickers For March 11, 2022: Tesla, DTE Energy, Amazon And More
Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news... 
Via Benzinga
Clover Health: Praying to the Great Google
Although CLOV stock is down, it still has institutional support. Its leaders have past ties to Google and a deal could help both companies. 
Via InvestorPlace
Is Clover Stock a Buy Right Now? Its 160% Revenue Growth Says Yes.
Off and on the price chart, CLOV stock is heading towards a better tomorrow and has much less to do with recent meme-driven news. 
Via InvestorPlace
Benzinga's Daily Brief On Trending Tickers For March 9, 2022: Crude Oil ETN, ZIM Integrated Shipping Services, GameStop And More
Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Kala Pharmaceuticals (NASDAQ:KALA) stock rose 86.8% to $1.14 during Tuesday's regular session. The current volume of 2.6 million shares is 326.2% of Kala... 
Via Benzinga
76 Biggest Movers From Yesterday
Gainers Houston American Energy Corp. (NYSE: HUSA) surged 494.7% to close at $11.30 on Monday amid continued momentum and an increase in the price of oil. Imperial Petroleum Inc... 
Via Benzinga
Why Is Clover Health (CLOV) Stock Up Today?
Clover Health is trading higher after director Chelsea Clinton disclosed a 100,000 share purchase. Who else is betting big on CLOV stock? 
Via InvestorPlace
Which Former President's Child Is Buying Shares Of Clover Health?
Clover Health Investments Corp (NASDAQ: CLOV) shares are surging Monday following insider buying from a prominent public figure. What Happened: According to a Form 4 filing ... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers TherapeuticsMD (NASDAQ:TXMD) stock moved upwards by 38.1% to $0.29 during Monday's regular session. As of 12:30 EST, TherapeuticsMD's stock is trading at a... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 CorteMadera.com & California Media Partners, LLC. All rights reserved.